These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3688595)

  • 41. The effect of activated charcoal on the absorption and elimination of astemizole.
    Laine K; Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1994 Jul; 13(7):502-5. PubMed ID: 7917508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid.
    el-Bahie N; Allen EM; Williams J; Routledge PA
    Br J Clin Pharmacol; 1985 Jun; 19(6):836-8. PubMed ID: 4027125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of activated charcoal administration on acetylcysteine serum levels in humans.
    North DS; Peterson RG; Krenzelok EP
    Am J Hosp Pharm; 1981 Jul; 38(7):1022-4. PubMed ID: 7258201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of activated charcoal on the absorption of amiodarone.
    Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1991 Sep; 10(5):327-9. PubMed ID: 1683545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevention of chloroquine absorption by activated charcoal.
    Neuvonen PJ; Kivistö KT; Laine K; Pyykkö K
    Hum Exp Toxicol; 1992 Mar; 11(2):117-20. PubMed ID: 1349217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of cholestyramine and activated charcoal on glipizide absorption.
    Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1990 Nov; 30(5):733-6. PubMed ID: 2271372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
    Gomez HF; McClafferty HH; Flory D; Brent J; Dart RC
    Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of activated charcoal in a simulated poisoning with acetaminophen: a new loading dose for N-acetylcysteine?
    Chamberlain JM; Gorman RL; Oderda GM; Klein-Schwartz W; Klein BL
    Ann Emerg Med; 1993 Sep; 22(9):1398-402. PubMed ID: 8363113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
    Gude AB; Hoegberg LC; Angelo HR; Christensen HR
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
    Mayersohn M; Perrier D; Picchioni AL
    Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of activated charcoal on aspirin absorption in man. Part I.
    Levy G; Tsuchiya T
    Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
    [No Abstract]   [Full Text] [Related]  

  • 53. Concomitant use of activated charcoal and N-acetylcysteine.
    Renzi FP; Donovan JW; Martin TG; Morgan L; Harrison EF
    Ann Emerg Med; 1985 Jun; 14(6):568-72. PubMed ID: 3994080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of aspirin absorption by activated charcoal and apomorphine.
    Decker WJ; Shpall RA; Corby DG; Combs HF; Payne CE
    Clin Pharmacol Ther; 1969; 10(5):710-3. PubMed ID: 5808464
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of current techniques for isolation of chars as natural adsorbents.
    Chun Y; Sheng G; Chiou CT
    Environ Sci Technol; 2004 Aug; 38(15):4227-32. PubMed ID: 15352465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adsorbent and cathartic inhibition of enteral drug absorption.
    Van de Graaff WB; Thompson WL; Sunshine I; Fretthold D; Leickly F; Dayton H
    J Pharmacol Exp Ther; 1982 Jun; 221(3):656-63. PubMed ID: 7086679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kerr Insta-Char Activated Charcoal Product.
    Saulson SS
    Am J Emerg Med; 1992 Jan; 10(1):97. PubMed ID: 1736926
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.
    Roberts DM; Southcott E; Potter JM; Roberts MS; Eddleston M; Buckley NA
    Ther Drug Monit; 2006 Dec; 28(6):784-92. PubMed ID: 17164695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated carbon from char obtained from vacuum pyrolysis of teak sawdust: pore structure development and characterization.
    Ismadji S; Sudaryanto Y; Hartono SB; Setiawan LE; Ayucitra A
    Bioresour Technol; 2005 Aug; 96(12):1364-9. PubMed ID: 15792584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.